Neuramis Lidocaine HA Filler(1 needle)
$27.00
Neuramis Lidocaine HA Filler combines 20mg/ml cross-linked hyaluronic acid with integrated 0.3% lidocaine for precise skin rejuvenation. Clinically validated for 9-month longevity with 83% patient satisfaction in Phase III trials, its SHAPE™ technology ensures homogeneous distribution (120-140μm particles, G’ 250-350 Pa) for natural results. Features Grade 1 swelling index for minimal downtime, 98.7% HA purity, and FDA/CE certified manufacturing. Delivers 72-hour post-treatment hydration with <0.4ppm BDDE residues.
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $25.92 |
| 16-30 | 6% | $25.38 |
| 31-Unlimited | 8% | $24.84 |
Neuramis Lidocaine HA Filler
Cross-Linked Hyaluronic Acid Dermal Filler with Integrated Anesthetic
Advanced Dermal Restoration
Medytox’s premium dermal filler combines 20mg/ml of cross-linked hyaluronic acid with 0.3% lidocaine for correction of skin imperfections. Clinically validated to deliver natural-looking results lasting 9 months (83% patient satisfaction in Phase III trials). Features BDDE residues <0.4ppm and 98.7% HA purity.
Core Clinical Benefits
Long-lasting Correction
9-month aesthetic persistence with cross-linked HA structure
Integrated Anesthesia
0.3% lidocaine for enhanced patient comfort
Minimal Downtime
Grade 1 swelling index for rapid recovery
Natural Integration
360° epidermal distribution creates seamless results
SHAPE™ Technology
Patented cross-linking process creates homogeneous HA matrix with optimized viscoelasticity (G’ 250-350 Pa) for precision placement in superficial to mid-dermis. Particle size optimized at 120-140μm for natural tissue integration and long-term persistence.
Packaging Specifications
Configuration
- Pre-filled sterile syringe
- 1 Needle (25-30G recommended)
- 1.0 mL fill volume per unit
Composition
- 20 mg/mL cross-linked hyaluronic acid
- 0.3% lidocaine HCl
- BDDE residues <0.4 ppm
Clinical Application Protocol
Injection Technique
- 30° needle insertion angle
- Retrograde linear threading technique
- Max 1.0 mL per treatment session
Post-Treatment Care
- Apply cold compress immediately
- Avoid pressure on treated areas
- 72-hour hydration monitoring
Key Considerations
Depth of injection significantly impacts results. Avoid vascular territories. Results may vary based on patient metabolism and tissue characteristics.
Medical Practitioner Advisory
For licensed professionals only. Contraindications include active skin infections, bleeding disorders, and lidocaine hypersensitivity. CE marked and manufactured in FDA-approved facilities. Product effects vary by technique and metabolism. Verify regional approval status before use.

Reviews
There are no reviews yet.